Hi, what are you looking for?
Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com
Cryptocurrency investors have experienced a real rollercoaster in the last few years — the likes of Bitcoin, Ethereum and Ripple have had incredible highs...
Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United...
Chinese researchers have unveiled a method of extracting uranium from seawater at a fraction of the previous cost and energy use, positioning the country...
A Malian court has postponed a critical decision on whether to place Barrick Mining’s (TSX:ABX,NYSE:B) flagship Loulo-Gounkoto gold complex under provisional administration The move...
Adam Rozencwajg, managing partner at Goehring & Rozencwajg, shares his latest thoughts on the gold, silver and uranium markets, also discussing why he’s bullish...
Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) announced on May 22 that Chief Executive Jakob Stausholm will step down later this year following a formal succession plan arranged...
Laramide Resources’ (TSX:LAM,ASX:LAM,OTCQX:LMRXF) Crownpoint-Churchrock and La Jara Mesa uranium projects in New Mexico have received covered project status under the federal FAST-41 permitting initiative....
While lead production figures are helpful in tracking year-to-year activity, lead reserves provide a longer-term picture of which nations are best positioned to dominate...
Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) (‘Athena Gold’ or the ‘Company’) is pleased to announce that it has entered into a property option agreement (the ‘Agreement’)...